Robert Thomas Freeman, Chief Financial Officer at Alignment Healthcare, Inc. (ALHC), sold 686,590 shares at $15.58 ($10.7M) on 2025-03-04, disclosed to the SEC on 2025-03-06.
Scheduled sale ($10.7M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.58 | 250,000 | $3.9M | 36.5% |
| 2 | $15.53 | 218,295 | $3.4M | 31.8% |
| 3 | $15.53 | 218,295 | $3.4M | 31.8% |
| Total | $15.55 avg | 686,590 | $10.7M | 100% |
| Filing → |
| ALHC | SELL | 2025-03-13 | $450K | — | Filing → |
| ALHC | SELL | 2024-11-13 | $409K | — | Filing → |
| ALHC | SELL | 2024-10-31 | $979K | — | Filing → |